Perthera is proud to have supported the advancement of clinical research efforts by providing physicians and clinical researchers the Precision Medicine Platform. The results of these publications have demonstrated increased OS and PFS patient survival rates, and have uncovered novel mutations that have been significant in treatment decision making.
The Lancet Oncology – Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial (March 2nd, 2020)
Surgical Oncology – A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution’s experience (February 8th, 2020)
JCO Precision Oncology – Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program (October 23rd, 2019)
Oncotarget – Multiplatform profiling of pancreatic neuroendocrine tumors: Correlative analyses of clinicopathologic factors and identification of co-occurring pathogenic alterations (October 22nd, 2019)